Skip to main content

Table 5 Results of the univariate and multivariate regression analyses for the predictive power of the individual components of the CHA2DS2-VASc-HSF score

From: New CHA2DS2-VASc-HSF score predicts the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction

Variables

Unadjusted OR(95% CI)

P value

Adjusted OR(95% CI)

P value

Male sex

0.82(0.46–1.45)

0.491

0.48(0.22–0.99)

0.048

Hypertension

1.67(1.03–2.71)

0.038

1.82(1.04–3.18)

0.035

Age 65–74 years

2.19(1.26–3.82)

0.006

3.33(1.76–6.32)

< 0.001

Age ≥ 75 years

2.86(1.43–5.71)

0.003

5.52(2.37–12.87)

< 0.001

Diabetes mellitus

1.697(0.995–2.895)

0.052

1.73(0.95–3.17)

0.076

History of heart failure

1.57(0.16–15.2)

0.70

2.06(0.18–23.99)

0.563

History of stroke/TIA

1.76(1.27–2.44)

0.001

2.11(1.45–3.07)

< 0.001

Vascular disease

3.27(1.92–5.57)

< 0.001

4.37(2.39–7.99)

< 0.001

Smoking

1.22(0.74–2.004)

0.435

1.77(0.93–3.38)

0.08

Hyperlipidemia

1.62(0.97–2.71)

0.063

2.71(1.499–4.92)

0.001

Family history

1.83(0.99–3.39)

0.054

2.67(1.299–5.50)

0.008

  1. Abbreviations: TIA transient ischemic attack, OR odds ratio, CI confidence interval